Nanalysis Scientific Corp. Announces $8 Million "Bought Deal" Public Offering

About this update from Nanalysis Scientific Corp

[{"type":"text","content":"\n \n \n \n Nanalysis Scientific Corp. Announces $8 Million \"Bought Deal\" Public Offering\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n \n \n \n CALGARY, AB\n \n ,\n \n July 29, 2021\n \n /CNW/ - (the \"\n \n Company\n \n \" or \"\n \n Nanalysis\n \n \"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Echelon Wealth Partners Inc. (the \"\n \n Underwriters\n \n \") pursuant to which the Underwriters have agreed to purchase 6,666,700 units (the \"\n \n Units\n \n \") from the treasury of the Company, at a price of\n \n $1.20\n \n per Unit (the \"\n \n Issue Price\n \n \") and offer them to the public by way of a short form prospectus for total gross proceeds of approximately\n \n $8,000,000\n \n (the \"\n \n Offering\n \n \"). Each Unit will consist of one common share of the Company (each a \"\n \n Common Share\n \n \") and one-half of one common share purchase warrant (each full warrant, a \"\n \n Warrant\n \n \" and collectively the \"\n \n Warrants\n \n \"). Each whole Warrant shall entitle the holder thereof to acquire one Common Share for an exercise price of\n \n C$1.70\n \n for period 24 months following the Closing Date.\n \n \n \n \n \n \n \n \n \n The Company has granted the Underwriters an option to purchase up to an additional 15% of the Units at the Issue Price. The Over-Allotment Option may be exercised in whole or in part to purchase Common Shares, Warrants or Units as determined by the Underwriters upon written notice to the Company at any time up to 30 days following the Closing Date (the \"\n \n Over-Allotment Option\n \n \").\n \n \n The Company intends to use the net proceeds of the Offering for sales, marketing, research and development, acquisitions, general administrative and working capital purposes.\n \n \n The Offering will be completed (i) by way of a sh...

More updates from Nanalysis Scientific Corp